Skip to content
10-K

Annual Report

MEDRESPONSE CORP.

0001477932-16-009317

← back to feed
Filed
Mar 30, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 10, 2016 9.56M sh
Capex restated FY 2015 · Dec 31, 2014 $692
Operating Cash Flow FY 2015 · Dec 31, 2014 −$15.12K
Current Liabilities FY 2015 · Dec 31, 2014 $6K
Total Liabilities FY 2015 · Dec 31, 2014 $6K
Current Assets FY 2015 · Dec 31, 2014 $13.63K
Total Assets FY 2015 · Dec 31, 2014 $14.29K
Operating Income FY 2015 · Dec 31, 2014 −$15.12K
Cash And Equivalents FY 2015 · Dec 31, 2013 $7.83K